Tag Archives: Pharmacy
Pharmacists: The Other White Coats
Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position, too, to move the needle on drug adherence.
Medco CEO Champions Robots Over Pharmacists
The role of the pharmacist in positive health outcomes – and drug company profits – is often cited in discussions around adherence to medication regimens, holistic prescribing practices and the navigation of insurance payment structures.
In an attempt to demystify that role, Medco CEO David Snow told attendees at the Cleveland Clinic’s Medical Innovation Summit last [...]
Posted in Regulatory, Strategy, patient education, pricing Also tagged CEOs, Medco, PBM, Pharmacists 22 Comments
AstraZeneca Signs Exclusive Distribution Deal for Vandetanib
As the number of drugs targeting small populations increases, managing numerous drug distribution channels and educating the relevant parties – specialty pharmacists, payers, physicians, and patients – becomes a daunting task. Specialty pharmacies that handle seven to 10 major disease states, after all, might only see three or four patients with a given rare disease, [...]
Posted in Deals, FDA, Legal, Market Access, Regulatory, Strategy, healthcare, pricing Also tagged distribution, Orphan Drugs, Ultra Orphan Leave a comment
Patient Adherence Awards Winners Revealed
Image via Wikipedia
The Center for Business Intelligence, on Monday, revealed winners of its annual Strategic Patient Adherence Awards as part of its two-day conference about patient compliance with their drug regiments.
This year’s award winners are:
Best Integrated Program—Shire Pharmaceuticals: FOSRENOL ON TRACK Direct To Patient Support Program
Best Disease State Program—BMS/Sanofi-Aventis Canada & Rx Canada: My Plavix [...]
Posted in Events, Strategy Also tagged Adherence Awards, Bristol Myers Squibb, CBI, Health care, Kaiser Permanente, Pfizer, pharmaceutical industry, Southern California, Walgreen Leave a comment

Congress, FDA Should Consider Tech Solutions for Safer Compounding